EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GRable Version 1.0: A Software Tool for Site-Specific Glycoform Analysis With Improved MS1-Based Glycopeptide Detection With Parallel Clustering and Confidence Evaluation With MS2 Information

Chiaki Nagai-Okatani, Daisuke Tominaga, Azusa Tomioka, Hiroaki Sakaue, Norio Goda, Shigeru Ko, Atsushi Kuno, Hiroyuki Kaji

Molecular & Cellular Proteomics · 2024

DOI: 10.1016/j.mcpro.2024.100833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2024. Verfasst von Chiaki Nagai-Okatani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular and Cellular Glycoproteomics Research Group, Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Indust…. Hauptthemen laut MEDLINE: Glycopeptides, Software, Polysaccharides. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-throughput intact glycopeptide analysis is crucial for elucidating the physiological and pathological status of the glycans attached to each glycoprotein. Mass spectrometry-based glycoproteomic methods are challenging because of the diversity and heterogeneity of glycan structures. Therefore, we developed an MS1-based site-specific glycoform analysis method named "Glycan heterogeneity-based Relational IDentification of Glycopeptide signals on Elution profile (Glyco-RIDGE)" for a more comprehensive analysis. This method detects glycopeptide signals as a cluster based on the mass and chromatographic properties of glycopeptides and then searches for each combination of core peptides and glycan compositions by matching their mass and retention time differences. Here, we developed a novel browser-based software named GRable for semi-automated Glyco-RIDGE analysis with significant improvements in glycopeptide detection algorithms, including "parallel clustering." This unique function improved the comprehensiveness of glycopeptide detection and allowed the analysis to focus on specific glycan structures, such as pauci-mannose. The other notable improvement is evaluating the "confidence level" of the GRable results, especially using MS2 information. This function facilitated reduced misassignment of the core peptide and glycan composition and improved the interpretation of the results. Additional improved points of the algorithms are "correction function" for accurate monoisotopic peak picking; one-to-one correspondence of clusters and core peptides even for multiply sialylated glycopeptides; and "inter-cluster analysis" function for understanding the reason for detected but unmatched clusters. The significance of these improvements was demonstrated using purified and crude glycoprotein samples, showing that GRable allowed site-specific glycoform analysis of intact sialylated glycoproteins on a large-scale and in-depth. Therefore, this software will help us analyze the status and changes in glycans to obtain biological and clinical insights into protein glycosylation by complementing the comprehensiveness of MS2-based glycoproteomics. GRable can be freely run online using a web browser via the GlyCosmos Portal (https://glycosmos.org/grable).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycopeptidesSoftwarePolysaccharidesHumansAlgorithmsCluster AnalysisProteomicsTandem Mass SpectrometryGlycoproteinsGlycosylationGlycomics

Stichwörter der Autor:innen

glycan heterogeneityglycoproteomicsretention timesite-specific glycoformsoftware

Substanzen

GlycopeptidesPolysaccharidesGlycoproteins

Autor:innen und Institutionen

  • Molecular and Cellular Glycoproteomics Research Group, Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan. Electroni…
  • Molecular and Cellular Glycoproteomics Research Group, Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan.
  • Department of Systems Medicine, Keio University School of Medicine, Shinjuku, Tokyo, Japan.
  • Molecular and Cellular Glycoproteomics Research Group, Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan; Institute…

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Nagai-Okatani, C., Tominaga, D., Tomioka, A., Sakaue, H., Goda, N., Ko, S., Kuno, A., & Kaji, H. (2024). GRable Version 1.0: A Software Tool for Site-Specific Glycoform Analysis With Improved MS1-Based Glycopeptide Detection With Parallel Clustering and Confidence Evaluation With MS2 Information. Molecular & Cellular Proteomics. https://doi.org/10.1016/j.mcpro.2024.100833

Vancouver

Nagai-Okatani C, Tominaga D, Tomioka A, Sakaue H, Goda N, Ko S, et al. GRable Version 1.0: A Software Tool for Site-Specific Glycoform Analysis With Improved MS1-Based Glycopeptide Detection With Parallel Clustering and Confidence Evaluation With MS2 Information. Molecular & Cellular Proteomics. 2024. doi:10.1016/j.mcpro.2024.100833

BibTeX
@article{NagaiOkatani2024,
  author = {Nagai-Okatani, Chiaki and Tominaga, Daisuke and Tomioka, Azusa and Sakaue, Hiroaki and Goda, Norio and Ko, Shigeru and Kuno, Atsushi and Kaji, Hiroyuki},
  title = {GRable Version 1.0: A Software Tool for Site-Specific Glycoform Analysis With Improved MS1-Based Glycopeptide Detection With Parallel Clustering and Confidence Evaluation With MS2 Information},
  journal = {Molecular & Cellular Proteomics},
  year = {2024},
  doi = {10.1016/j.mcpro.2024.100833}
}
Kostenlos starten →